Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Durham, NC
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Cleveland, OH
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Dallas, TX
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Seattle, WA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Seattle, WA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Marshfield, WI
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Marshfield, WI
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Darlinghurst,
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Darlinghurst,
Click here to add this to my saved trials
Aspiring to Awesome- Patient Preference Privacy Selections in EMR
Aspiring to Awesome- Patient Preference Privacy Selections in EMR
Status: Enrolling
Updated:  12/20/2017
Wishard Health Services, Primary Care Center
mi
from
Indianapolis, IN
Aspiring to Awesome- Patient Preference Privacy Selections in EMR
Aspiring to Awesome- Patient Preference Privacy Selections in EMR
Status: Enrolling
Updated: 12/20/2017
Wishard Health Services, Primary Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain
Status: Enrolling
Updated:  12/20/2017
TX
mi
from
Webster, TX
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain
Status: Enrolling
Updated: 12/20/2017
TX
mi
from
Webster, TX
Click here to add this to my saved trials
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated:  12/20/2017
TCR Medical Corporation
mi
from
San Diego, CA
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated: 12/20/2017
TCR Medical Corporation
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated:  12/20/2017
Yale Center for Clinical Investigation
mi
from
New Haven, CT
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated: 12/20/2017
Yale Center for Clinical Investigation
mi
from
New Haven, CT
Click here to add this to my saved trials
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated:  12/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated: 12/20/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated:  12/20/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated: 12/20/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated:  12/20/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Status: Enrolling
Updated: 12/20/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Asthma Data Innovation Demonstration Project
Asthma Data Innovation Demonstration Project: Impact of a Mobile Health, Sensor-driven Asthma Management Platform on Asthma Symptoms, Control and Self-management
Status: Enrolling
Updated:  12/23/2017
Jefferson County
mi
from
Louisville, KY
Asthma Data Innovation Demonstration Project
Asthma Data Innovation Demonstration Project: Impact of a Mobile Health, Sensor-driven Asthma Management Platform on Asthma Symptoms, Control and Self-management
Status: Enrolling
Updated: 12/23/2017
Jefferson County
mi
from
Louisville, KY
Click here to add this to my saved trials
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated:  12/27/2017
The University of California, San Diego
mi
from
La Jolla, CA
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated: 12/27/2017
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated:  12/27/2017
New York University Langone Medical Center
mi
from
New York, NY
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Status: Enrolling
Updated: 12/27/2017
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders
Status: Enrolling
Updated:  12/29/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders
Status: Enrolling
Updated: 12/29/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Status: Enrolling
Updated:  1/1/2018
UCSF Helen Diller Comprehensive Cancer Center
mi
from
San Francisco, CA
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Status: Enrolling
Updated: 1/1/2018
UCSF Helen Diller Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated:  1/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated: 1/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated:  1/3/2018
Cleveland Clinic Children's
mi
from
Cleveland, OH
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated: 1/3/2018
Cleveland Clinic Children's
mi
from
Cleveland, OH
Click here to add this to my saved trials
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated:  1/3/2018
Texas Children's Hospital
mi
from
Houston, TX
Diagnosing Respiratory Disease in Children Using Cough Sounds
Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds
Status: Enrolling
Updated: 1/3/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Medical University of South Carolina
mi
from
Charleston, SC
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
City of Hope National Medical Center
mi
from
Duarte, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
UCLA Medical School
mi
from
Los Angeles, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
UCLA Medical School
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Kentucky
mi
from
Lexington, KY
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Massachusetts General Hospital
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Boston University School of Medicine
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Michigan
mi
from
Ann Arbor, MI
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Duke University
mi
from
Durham, NC
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Texas- Houston Medical School
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Calgary
mi
from
Calgary,
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-Line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients With Stage II and III Ovarian Carcinoma
Status: Enrolling
Updated:  1/5/2018
James Graham Brown Cancer Center
mi
from
Louisville, KY
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-Line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients With Stage II and III Ovarian Carcinoma
Status: Enrolling
Updated: 1/5/2018
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged Two to Six Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated:  1/7/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged Two to Six Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated: 1/7/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Ucsf Aids Crs
mi
from
San Francisco, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Ucsf Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Denver Public Health CRS
mi
from
Denver, CO
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Denver Public Health CRS
mi
from
Denver, CO
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Stanford CRS
mi
from
Palo Alto, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Stanford CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Ucsd, Avrc Crs
mi
from
San Diego, CA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Ucsd, Avrc Crs
mi
from
San Diego, CA
Click here to add this to my saved trials